I’m encouraged by the sentiment that the sales team are really starting to gain momentum.
Also like the continued rhetoric that they will exceed 200%.
IMO this quarterly due out in December will give us an idea as to how far past 200% they will go. This is the busy quarter in the states apparently.
It will be interesting to see how other territories are going as well. There is the NHS trial in the UK that is still to be discussed - this could be huge. Watch out for an announcement that Valpara Enterprise is in some big UK hospital. They seem to be doing it the right way - get the big boys on board showing the way and the others will follow. Then there is also our first sale in Taiwan after approval. I’m looking forward to this also.
It’s going to be an exciting 6 months.
Remember revenue is recognised at the end of the period not at sale.
VHT Price at posting:
64.0¢ Sentiment: Buy Disclosure: Held
